We used either the synthetic androgen R1881 (methyltrienolone) or 5a-dihydrotestosterone (5a-DHT) to characterize androgen receptors in rat aortic and myocardial cytoplasmic and nuclear preparations. Relative steroid specificity studies established that only androgens were effective inhibitors of R1881 (cytoplasmic) or 5a-DHT (nuclear) binding to aortic and myocardial androgen receptors, whereas estrogens, progestins, and cortisol were ineffective inhibitors. Low ionic strength sucrose density gradient centrifugation analyses showed that androgen receptors in aortic and myocardial cytoplasmic preparations migrated as macromolecules with sedimentation coefficients of 8 to 9S, whereas androgen receptors in aortic and myocardial nuclear preparations migrated as macromolecules with sedimentation coefficients of 4 to 5S (high ionic strength buffer). Saturation analyses established that aortic and myocardial cytoplasmic preparations from intact, untreated young mature female rats contained 45.8 ± 9.7 (mean ± SD) and 63.3 ± 20.7 fmol androgen receptor/mg DNA, respectively. The respective R1881 dissociation constants were 0.60 and 0.32 nM. Androgen receptors could not be demonstrated in nuclear preparations from the cardiovasculature of intact females. Testosterone injection of intact young mature female rats caused apparent depletion of androgen receptors in aortic and myocardial cytoplasmic preparations and resulted in concomitant appearance of 57.1 ± 22.2 and 52.3 ± 21.5 fmol receptor/mg DNA in the corresponding nuclear preparations. The respective 5a-DHT dissociation constants were 4.46 and 1.63 nM. The ability of testosterone to affect apparent intracellular distribution of cardiovascular androgen receptors suggests that the receptors are physiologically functional and indicates that androgen may directly regulate cardiovascular cell function. (Arteriosclerosis 5:659-667, November/December 1985)
acteristic of selected lysosomal hydrolases and cytochrome C oxidase activities of mouse aorta 5 or myocardium 6 and rat aortic acid cholesterol esterase activity. 7 The differences in enzyme activity are diminished by gonadectomy of males or testosterone treatment of females. Both autoradiographic and biochemical data establish the presence of androgen binding components in rat, 8S canine, 10 and baboon cardiovasculature. 11 " 14 While these data imply androgen regulation of cardiovascular cell function, none of the studies characterized nuclear androgen binding components, established an in vivo effect of androgens on androgen binding component distribution between nuclear and cytoplasmic fractions, or described a relationship between tissue androgen binding component content or distribution and cardiovascular cell function.
The syndromes of male pseudohermaphroditism due to androgen resistance result from defects in androgen metabolism or androgen receptor content or function in the anlage of the accessory sex organs. 1516 Characteristic receptor defects include: 1) absent or diminished tissue receptor content; 17 " 19 2) altered physical properties that apparently affect function; 19 " 21 and 3) impaired capacity for nuclear retention. 22 These studies establish that the presence of cytoplasmic androgen binding components in a presumed target tissue is not necessarily correlated with functionality. The results of these studies raise concern about the physiologic significance of previously described cardiovascular androgen binding components. As part of a more detailed evaluation of the hypothesis that cardiovasculature is an androgen target tissue, we charactertized rat aortic and myocardial cytoplasmic and nuclear androgen receptors and in vivo effects of androgen on androgen receptor localization. The results of these analyses are described in this report.
Methods

Animals
We used male or female inbred mature AXC rats from the colony at Southwest Foundation for Biomedical Research. The origin and maintenance of this colony have been described in detail. 23 Bilateral orchiectomy was performed aseptically through a midline scrotal incision while rats were maintained under light ether anesthesia. Rats were lightly anesthetized with ether and then killed by cervical dislocation. In general, the aorta and myocardium were removed, freed of fascia, blotted to remove excess blood, placed on ice-cold aluminum foil, and used immediately. In selected instances, isolated aorta were wrapped in aluminum foil, sealed in heatsealed packets, frozen by compression between blocks of dry ice, and transferred, without delay, to a -90°C freezer where they were stored until analyzed. All procedures were performed in accordance with guidelines established by the Department of Health and Human Services for the treatment of laboratory animals and were approved by the Animal Research Committee of the Southwest Foundation.
Chemicals
[17a-Methyl-3 H3]R1881 (methyltrienolone, specific activity 87 Ci/mmole), radioinert R1881, [1,2,4,5,6,7,16,17 -3 He]5a-dihydrotestosterone (5a-DHT, specific activity 208 Ci/mmole), radioinert R5020 (promegestone), and radioinert R2858 (moxestrol) were obtained from New England Nuclear Corporation, Boston, Massachusetts and were used as provided by the manufacturer. Triamcinolone acetonide, DNA (salmon testes, type III), and bovine serum albumin (Fraction 5) were obtained from Sigma Chemical Company, St. Louis, Missouri. Radioinert steroids were obtained from Steraloids, Incorporated, Wilton, New Hampshire. Human y-globulin was from Calbiochem-Behring Corporation, La Jolla, California. Dextran T70 was from Phar-macia Fine Chemicals, Incorporated, Piscataway, New Jersey. Hydroxylapatite (DNA grade, Bio-Gel HTP) was from Bio-Rad Laboratories, Richmond, California. Other materials were the highest quality reagent grade available from the manufacturer. All solutions were prepared in water which had been distilled, deionized, and redistilled from glass.
Preparation of Cytoplasmic Extracts and Quantltatlon of Total Androgen Receptor Content by Saturation Analysis
Aortic and myocardial cytoplasmic extracts were prepared by a slight modification of previously described methods. 12 -13 In brief, fresh tissues were cooled on ice or frozen tissues were thawed on ice and subsequent procedures were performed at 2° to 4°C. Tissues were finely minced and then homogenized in a glass-glass homogenizer in 3 to 4 volumes of buffer T^E^D^S .^ (50 mM Tris-HCI, 0.1 mM EDTA, 10 mM dithiothreitol, 380 mM sucrose, pH 7.4). Homogenates were centrifuged at 50 K x g at 2°C for 5 minutes, and supernatants were made 20 mM in sodium molybdate, 1 mM in phenylmethylsulfonyl fluoride and incubated at 2°C with 0.1 volume of dextran y-globulin coated charcoal (DGCC) suspension [5% charcoal, 0.5% dextran, 1% -y-globulin (wt/vol)] in buffer T^E^D^ (buffer T^E^D^S^,, without sucrose) for 10 minutes. Charcoal was removed by centrifugatlon for 15 minutes at 200 K x gat 2°C. Clarified supernatants were made 2.2 piM in triamcinolone acetonide (TA), to block R1881 binding to putative progesterone receptors. 12 ' 13 Incubations were performed at 2°C for 20 to 24 hours in a final volume of 220 ^l buffer TsoEo.AoSaw containing 100 /xl tissue extract and various concentrations of radiolabeled R1881 (0.1 to 5 nM). Nonspecific binding was determined in a parallel series of identical incubations that additionally contained 1.0 /xM radioinert R1881. Specific and nonspecific binding were quantitated in duplicate incubates at each ligand concentration. Mean values were used to calculate specific binding as the difference in radioligand bound in the absence and presence of radioinert ligand after the latter data were corrected for dilution of radiolabeled probe by radioinert probe. 24
Preparation of Nuclear Extracts and Quantltatlon of Total Androgen Receptor Content by Saturation Analysis
The 50 K x g pellets obtained from the preparation of cytoplasmic extracts were suspended in buffer T 10 E 15 C 5 (10 mM Tris-HCI, 1.5 mM EDTA, 5 mM CaCI ? , pH 7.4), passed through a layer of fine nylon stocking, collected by centrifugation (50 K x g for 5 minutes), and washed three times with buffer T 1O E 1-S C 5 by suspension and recentrifugation. After removing an aliquot for DNA analysis, the washed nuclear pellets were sonicated and extracted with 4 to 5 ml/g tissue, using buffer BBPP [20 mM sodium barbital, 1.5 mM EDTA, 150 mM KCI, 5 mM dithiothreitol, 5 mM pyridoxal-5'-phosphate, 20% glycerol (vol/vol), pH 8.0 (at 20° C)], by incubation in the dark at 2° C for 30 minutes. 25 Clarified nuclear extract was obtained by centrifugation for 45 minutes at 200 K x g. Duplicate incubations were performed at 2° C for 18 to 24 hours in a final volume of 440 /xl buffer BBPP containing 200 n\ nuclear extract and various concentrations of radiolabeled 5a-DHT (0.5 to 10 nM). Nonspecific binding was determined in a parallel series of identical duplicate incubations that additionally contained 1.0 nM radioinert 5a-DHT. Specific binding was calculated as described in the preceding section.
Separation of Bound and Free Radlollgand by Hydroxylapattte (HAP) Adsorption
Hydroxylapatite was prepared essentially according to the method of Trachtenberg et al. 28 At termination of incubation, 250 /xl (cytoplasmic) or 400 /xl (nuclear) of HAP in 50 mM Tris-HCI, 0.1 mM EDTA, oH 7.4 (at 4° C), was added to incubates. After incubation for 30 minutes at 2° C (gently vortexing every 10 minutes), HAP was pelleted (1 K x g, 2° C) and washed three times by suspension and sedimentation in the same buffer. Washed HAP pellets were frozen by placing tubes in an acetone-dry ice bath and pellets were transferred to individual counting vials. Thawed pellets were wetted with 1 ml ethanol, and their tritium content was quantitated by liquid scintillation spectrometry. Specific binding data were evaluated by the method of Scatchard 27 and as double reciprocal plots. 28
Characterization of Steroid Specificity of R1881 and 5a-DHT Binding to Rat Aortic and Myocardlal Androgen Receptors
Conditions of incubation and determination of bound radiosteroid were as described in the preceding sections. Relative steroid specificity was determined by the single concentration inhibition assay previously used by us. 12 -13 
Sucrose Density Gradient Characterization of Androgen Receptors In Cytoplasmic and Nuclear Preparations
Sucrose density gradient centrifugation to characterize androgen receptors in cytoplasmic preparations was performed on linear 10% to 30% gradients in the Son/all vertical tube rotor (TV 865) under conditions previously described. 12 -13 Sucrose density gradient analyses of androgen receptors in nuclear preparations were done with extracts prepared from testosterone-injected rats. After incubating extracts for 18 hours at 4° C with 1 nM radiolabeled 5a-DHT in the absence or presence of 1 /iM radioinert 5a-DHT (final volume 4.1 ml), 2.8 ml of HAP slurry was added and incubation was continued for 30 minutes at 4° C (gently vortexing every 10 minutes). HAP was col-lected by centrifugation, washed four times as described in the preceding section, and 0.25 ml 1 M phosphate buffer (pH 7.4) was added to the washed HAP pellet. Following a 30-minute incubation at 4° C (vortexing every 10 minutes), clarified extracts were obtained by centrifugation at 1 K x gfor 6 minutes. A second 0.3 ml phosphate buffer extraction of the HAP pellet was then performed. Two hundred fifty microliters of the first and second extracts were layered onto individual 20% to 40% linear sucrose gradients containing 20 mM sodium barbital, 1.5 mM EDTA, 0.5 M KCI, 5 mM dithiothreitol, and 15% glycerol (pH 8.0, at 20° C) which were developed by centrifugation for 12 hours at 370 K x g in the Sorvall vertical tube rotor (TV 865). Human y-globulin served as sedimentation standard. At least two independent analyses were performed.
Other Methods
Protein was determined by the procedure of Lowry et al. 29 using bovine serum albumin as the standard. DNA was determined by the fluorometric method of Vytasek 30 using salmon testes DNA as the standard. Sample preparation for quantitation of radioisotope was as previously described. 12 -13 Tritium was quantitated in either a Beckman 7800 or 7500 scintillation spectrometer and most samples were counted to 2% precision (at the 95% confidence level).
Results
Effect of Incubation Interval on Radiolabeled R1881 Binding In Rat Myocardlal and Aortic Cytoplasmic Extracts
Time course determinations showed that maximum binding of R1881 to rat myocardial and aortic androgen receptors in cytosol of 24-hour orchiectomized rats occurred during 2 to 4-hours of incubation at 2° C and was maintained through at least 22 hours of incubation ( Figure 1 ). When we added a 500-fold excess of radioinert R1881 (final concentration 1 IMM) to rat myocardial or aortic cytoplasmic extracts, which had been incubated with 2 nM radiolabeled R1881 for 2 hours at 2° C, and continued incubation at 2° C, we observed rapid displacement of radiolabeled R1881 (Figure 1 ). Exchange of radioinert and radiolabeled R1881 occurred with a t 1/4 of approximately 6 to 8 or 12 to 14 hours in aortic and myocardial extracts, respectively. Incubation of myocardial extracts at 60° C for 1 hour in the absence of radiolabeled probe and sodium molybdate caused complete inactivation of R1881 binding components (data not shown).
Characterization of Relative Steroid Specificity of R1881 or 5a-DHT Binding to Androgen Receptors In Rat Myocardlal and Aortic Cytoplasmic or Nuclear Preparations
Single concentration determinations of the ability of selected steroids to inhibit R1881 binding to an-Incubation Intervol (hr) Figure 1 . Effect of incubation interval and inclusion of radioinert R1881 on radiolabeled R1881 binding to androgen receptors in rat myocardial (A) and aortic (B) cytoplasmic preparations. Tissues were obtained from male rats at 24 hours after orchiectomy. Incubation mixtures contained 2 nM radiolabeled R1881 (o). After incubation for 2 hours at 2°C, a parallel incubate was brought to 1 ^M in radioinert R1881, and incubation at 2°C was continued (•). Other procedures are described in the text. Reported data have had background subtracted. drogen receptors in myocardial and aortic cytoplasmic preparations showed (Table 1 ) that 5a-DHT and testosterone were effective inhibitors, whereas estradiol-173, R2858, progesterone, R5020, and cortisol were ineffective inhibitors. Androgen receptors could not be detected in nuclear preparations from cardiovasculature of intact female rats. Testosterone injection of intact female AXC rats consistently generated androgen receptors in myocardial and aortic nuclear preparations. Evaluation of the relative ability of selected steroids to inhibit 5a-DHT binding to androgen receptors in myocardial and aortic nuclear preparations showed that R1881 and testosterone were effective inhibitors, whereas progesterone, R5020, estradiol-17(3, R2858, triamcinolone acetonide and cortisol were ineffective inhibitors ( Table 1) .
Sucrose Density Gradient Characterization of Androgen Receptors In Rat Myocardial and Aortic Preparations
Low ionic strength linear 10% to 30% sucrose density gradient analyses ( Figure 2 ) showed that myocardial and aortic cytoplasmic extracts contained a major peak of R1881 binding with a sedimentation coefficient of 8S to 9S. Competition experiments showed that myocardial or aortic cytoplasmic R1881 binding was effectively eliminated by excess radioinert R1881 (Figure 2 ). High ionic strength linear 20% to 40% sucrose density gradient analyses ( Figure 3 ) showed that myocardial and aortic nuclear extracts contained a major peak of 5a-DHT binding with sedimentation coefficient of 4S to 5S. Competition experiments showed that nuclear 5a-DHT binding was effectively eliminated by excess radioinert 5a-DHT ( Figure 3 ).
Quantltatlon of Androgen Receptor Content of Rat Myocardial and Aortic Cytoplasmic and Nuclear Preparations
To assess the reproducibility and accuracy of these determinations, we prepared a single myocar- Data are the means of duplicate independent determinations (nuclear) or from representative determinations (cytoplasmic). NP = determination not performed.
•Radiolabeled R1881 was used as probe of androgen receptors in cytoplasmic preparations. Probe concentration was 2 nM, myocardium, or 1 nM, aorta. Competitor concentration was 100-fold molar excess. Tissues were obtained from male rats at 24 hours after orcniectomy. Incubation was at 2° C for 20 to 24 hours. tRadiolabeled 5a-DHT was used as probe of androgen receptors in nuclear preparations. Probe concentration was 3 nM, myocardium, or 2 nM, aorta. Competitor concentration was 100-fold molar excess. Tissues were obtained from female rats at 1.5 hours after injection (i.p.) of 1.0 mg testosterone in ethanol:cottonseed oil (5:95). Incubation was at 2° C for 20 to 24 hours. After separating free and receptor-bound ligand by HAP adsorption, receptors bound to HAP were eluted with 1 M phosphate buffer as described in the text and extracts were applied to linear sucrose density gradients (20% to 40% sucrose containing 15% glycerol) which were developed by centrifugation at 370 K x g (TV 865 vertical rotor) at 2 °C for 12 hours. Sedimentation is from left to right. The sedimentation coefficient of human •y-globulin (arrow) is 7S. The specific binding in peaks in panels A and B contain 2.67 and 1.42 fmol 5a-DHT, respectively, and the concentration of binding components in these preparations was 1.29 and 0.70 pM, respectively. Differences in receptor concentration reflect differences in the amount of tissue used for each preparation. Reported DPM have had background subtracted. dial cytoplasmic and nuclear extract and divided each preparation into three aliquots. These were used for simultaneous, independent determination of site content by saturation analysis. The saturation (Figure 4 ) and Scatchard plots ( Figure 5 ) of these data establish that ligand binds to a single class of high affinity, limited capacity binding sites. Cytoplasmic 13.3 ± 0.77 fmol/ml (mean ± SD) and nuclear . Saturation plots of R1881 binding to cytoplasmic and 5a-dihydrotestosterone binding to nuclear androgen receptors as determined in replicate analyses. Cytoplasmic and nuclear extracts were prepared from rat myocardium and each was divided into three aliquots. . Each aliquot was used for an independent saturation analysis in which total and nonspecific binding were determined in duplicate at each ligand concentration. Specific binding, calculated from mean values for the duplicate determinations, is reported. For each ligand concentration, the percent difference between the mean value and individual determinations was calculated. These data were used to calculate a mean value for all determinations. The values for cytoplasmic total and nonspecific binding data were 2.1% ± 1.2% (mean ± SD) and 4.1% ± 2.7%, respectively. The respective values for nuclear determinations were 2.4% ± 2.3% and 3.3% ± 3.0%. 5 and 6 ) demonstrate that R1881 is binding to limited capacity, high affinity binding sites in both aortic and myocardial cytoplasmic extracts. Cytoplasmic sites are saturated at 2 to 3 nM ligand. Saturation analysis of nuclear extracts prepared from myocardium or aorta of testosterone-injected intact females consistently showed evidence of limited capacity, high affinity binding of 5a-DHT that was saturated at 3 to 6 nM ligand, whereas identical extracts prepared from myocardium or aorta of intact female AXC rats consistently failed to have demonstrable, saturable 5a-DHT binding components ( Figure 6 ).
Typical Scatchard plots of saturation data (Figures
Androgen-Medlated Nuclear Localization of Cytoplasmic Fraction Androgen Receptors
Injection of intact female AXC rats with testosterone caused a 90% reduction in androgen receptor content of aortic cytoplasmic preparations which was quantitatively accounted for by the appearance of androgen receptors in nuclear preparations from the same tissues (Table 2) . Total aortic androgen receptor content of testosterone-injected female rats was not significantly different from the cytoplasmic fraction androgen receptor content of control females, p < 0.5 ( Table 2 ). Injection of intact females with testosterone caused partial (50%) depletion of androgen receptor content of myocardial cytoplasmic preparations and comparably increased androgen receptor content of nuclear preparations from the same tissues (Table 2) . Total myocardial androgen receptor content of testosterone-injected female rats was not significantly different from myocardial cytoplasmic fraction androgen receptor content of control females, p < 0.5 ( Table 2 ). The precision of these determinations, as assessed by the coefficient of Data are the means ± so of three or four independent determinations. Each independent determination was performed with cytoplasmic and nuclear preparations from the same tissue pool. Values for site content were obtained by linear regression analysis of double reciprocal plots of the saturation data. Regression correlation coefficients for cytoplasmic and nuclear preparation site content were 0.968 ± 0.03 (mean ± SD), aorta; 0.962 ± 0.04, myocardium. Receptor content, fmol/mg protein, of cytoplasmic preparations was: aorta: 2.49 ± 0.59 (mean ± so) control, and 0.35 ± 0.71, testosterone; myocardium: 3.11 ± 0.23, control, and 1.64 ± 0.06, testosterone. Differences were significant, p < 0.01. The DNA content of aorta and myocardium of female AXC rats respectively was 2.23 ± 0.40 and 2.50 ± 0.63 mg/g tissue.
'Intact, young-mature (6-to 8-month-old) females either did or did not receive a testosterone injection, as described in the footnote to Table 1. tSigntficantly different from control subjects, p < 0.02 by one-way analysis of variance. The large value of the coefficient of variation for the aortic cytoplasmic analyses reflects the fact that three of four individuals had undetectabie cytoplasmic receptor content. These data therefore are more a reflection of the frequency of complete receptor depletion than a measure of assay precision. variation for the individual measurements, is comparable to the intraassay variation ( Figures 5 and 6 ). The steroid dissociation constants for aortic and myocardial cytoplasmic fraction androgen receptors respectively were 0.60 ± 0.31 nM (mean ± SD) and 0.20 ± 0.05 nM, whereas respective steroid dissociation constants for nuclear fraction androgen receptors were 4.46 ± 0.77 nM and 1.63 ± 0.53 nM.
Discussion
In this study we have characterized cytoplasmic and nuclear androgen binding components in rat aorta and myocardium. These androgen binding components are androgen receptors as established by the following evidence: 1) relative steroid specificity ( Table 1 ) which shows that only androgens are effective inhibitors of R1881 or 5a-DHT binding, whereas estrogens, progestins, and cortisol are ineffective inhibitors; 2) sedimentation properties on linear sucrose density gradients, which establish that cytoplasmic R1881 binding components are macromolecules with sedimentation coefficients of 8S to 9S in low ionic strength gradients (Figure 2) , whereas nuclear 5a-DHT binding components are macromolecules with sedimentation coefficient of 4S to 5S in high ionic strength gradients (Figure 3) ; 3) the properties of limited capacity, high affinity binding (Figures 4 and 5) ; 4) androgen-mediated nuclear localization of cytoplasmic fraction androgen receptors ( Table 2 and Figure 6 ), and 5) temperature instability.
Our assays for androgen receptors of rat aortic and myocardial preparations represent a significant modification of prior protocols used for characterization of steroid receptors in baboon cardiovascular tissue. 12 ' 13 These changes were necessitated by the need to improve precision and sensitivity in order to reliably quantitate low receptor content. Our data ( Figures 4-6 and Table 2 ) establish that these objectives have been achieved. Because R1881 readily exchanges with steroid occupied cytoplasmic fraction androgen receptor sites of rat aorta ( Figure 1B) , cytoplasmic fraction receptor site content determined in these studies probably represents the total androgen receptor content. Exchange of R1881 with steroid occupied myocardial cytoplasmic fraction androgen receptor sites appears to be less complete during the period of incubation (Figure 1 A) . This suggests that reported apparent site content of this tissue ( Table 2 ) may underestimate by approximately 20% the total myocardial cytoplasmic fraction androgen receptor content.
A considerable body of data supports the concept that steroid hormones regulate gene expression through binding of hormone to cytoplasmic receptors. Subsequent facilitated transport of hormone/ receptor complexes into the nucleus and specific interaction of hormone/receptor complex with chromosomal regulatory elements results in regulation of gene expression. 31 " 33 Notable exceptions to this generalized model have been the observations that both thyroid hormone 34 and vitamin D 35 receptors are located in the nucleus and that rat dorsolateral prostate androgen receptors are restricted to the nucleus. 36 Recently, autoradiographic, 37 immunochemical, 3839 and biochemical 40 studies have suggested that cytoplasmic steroid hormone receptors may arise as a consequence of an experimental artifact that permits redistribution of a nuclear receptor that had been weakly associated with nuclear components. Consequently, a generalized model of steroid hormone action is not now well defined. Our data ( Table 2 ) that establish an in vivo androgen-mediated nuclear localization of androgen receptor in cells of rat cardiovasculature are consistent with the anticipated properties of functional hormone receptors as predicted by previous 32 -M or current studies. 3840 Androgen receptor content of rat cardiovasculature is relatively low, 40 to 90 fmol/mg DNA (current studies). However, comparable low levels of androgen receptor appear to have a physiologically significant role as shown by the quantitative relationship between renal ornithine decarboxylase activity and nuclear fraction androgen receptor content of male and female mouse kidney. 41 Our present data thus provide strong support for the hypothesis that the cardiovasculature is an androgen target tissue whose function may be subject to direct modulation by androgens.
